Santoro S A, Cowan J F
Biochim Biophys Acta. 1984 Feb 14;797(2):178-85. doi: 10.1016/0304-4165(84)90120-x.
In the presence of ristocetin, von Willebrand factor is capable of agglutinating washed platelets. Modification of only a small percentage of amino groups of von Willebrand factor with trinitrobenzenesulfonic acid markedly inhibits this platelet agglutinating activity. 90% of the platelet agglutinating activity is lost after modification of only 10% of the von Willebrand factor amino groups. Since only the higher molecular weight forms of the heterogeneous von Willebrand factor polymers possess this platelet agglutinating activity, it was important to demonstrate that trinitrophenylation did not alter the degree of von Willebrand factor polymerization. This was accomplished by agarose gel electrophoresis. Subsequent direct binding and competitive binding studies demonstrated that trinitrophenylation markedly impairs the ability of von Willebrand factor to bind to the platelet surface. Thus the loss of platelet agglutinating activity upon modification of only a small fraction of the amino groups of von Willebrand factor is attributable to impaired binding of the modified von Willebrand factor to the platelet surface.
在存在瑞斯托菌素的情况下,血管性血友病因子能够使洗涤过的血小板发生凝集。用三硝基苯磺酸仅修饰血管性血友病因子一小部分氨基,就能显著抑制这种血小板凝集活性。仅修饰10%的血管性血友病因子氨基后,90%的血小板凝集活性丧失。由于只有异质性血管性血友病因子聚合物的较高分子量形式具有这种血小板凝集活性,因此证明三硝基苯化不会改变血管性血友病因子的聚合程度很重要。这是通过琼脂糖凝胶电泳完成的。随后的直接结合和竞争性结合研究表明,三硝基苯化显著损害了血管性血友病因子与血小板表面结合的能力。因此,仅修饰血管性血友病因子一小部分氨基后血小板凝集活性的丧失,归因于修饰后的血管性血友病因子与血小板表面结合受损。